Bovie Medical Corporation APYX 深 沪
等待开盘 09-03 09:30:00 美东时间
1.9803
-0.010
-0.49%
华盛通- 最 高1.9875
- 今 开1.94
- 成交量 4.71万股
- 最 低 1.87
- 昨 收 1.99
- 总市值 7489.40万
- 52周最高 2.73
- 市盈率 静 --
- 换手率 0.12%
- 52周最低 0.7554
- 委 比 -48.98%
- 总股本 3781.95万
- 历史最高 17.50
- 量 比 1.19
- 振 幅 5.90%
- 历史最低 0.7554
- 每 手 1
- 风险率 0.39%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Apyx Medical Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Apyx Medical Corporation granted John Featherstone, its Vice President of North American Sales, a nonstatutory stock option to purchase 100,000 shares on August 4, 2025. The option has an exercise price of $1.85 and vests over four years, with 25% of shares vesting annually. Apyx Medical, an advanced energy technology company, develops innovative medical devices, including Renuvion® and J-Plasma®, supported by over 90 clinical documents. The comp...
08-07 20:06
Apyx Medical Expands Global Sales Leadership with Strategic Hires to Support AYON Launch and Accelerated Growth
Apyx Medical Corporation announced the appointments of John Featherstone as Vice President of North American Sales and Simon Davies as Director of International Sales, Europe and Asia-Pacific. Both executives bring extensive industry experience and will drive the global expansion of the company's AYON Body Contouring System and other products.
08-07 20:05
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
Apyx Medical Corporation to Participate in the Canaccord Genuity 45th Annual Growth Conference
Apyx Medical Corporation announced that its President and CEO, Charlie Goodwin, and CFO, Matt Hill, will participate in the Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 in Boston. They will engage in a fireside chat at 4:00pm ET, accessible via live webcast and replay on the company’s Investor Relations website. The event provides investors with opportunities to meet management and learn about Apyx Medical’s advanced energy ...
07-30 20:20
Apyx Medical Launches Renuvion In China
Strong clinical interest and early procedures completedEntered into distribution agreement with GlamMoon, a division of BeauCare Clinics Investment Co., Ltd. post-initial market clearance
07-28 20:03
Apyx Medical Corporation Announces Launch of Renuvion® in China
<p>filter_html_lambda = lambda text: BeautifulSoup(text, 'html.parser').get_text(strip=True)</p> # 过滤HTML标签 <p>filtered_text = filter_html_lambda(original_text)</p> <p><strong>Summary:</strong></p> <p>Apyx Medical Corporation has launched Renuvion® in China as part of its global expansion strategy. The company entered into a distribution agreement with GlamMoon, a division of BeauCare Clinics Investment Co., Ltd., following market clearance f...
07-28 12:00
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025
Apyx Medical Corporation will release its Q2 2025 financial results after market close on August 7, 2025. A conference call to discuss the results and answer questions will be held at 4:30 p.m. ET on the same day. Interested parties can join via phone at 800-717-1738 (or 646-307-1865 for international callers) with access code 35370, or via a live webcast available on the company’s Investor Relations website. Apyx Medical, a leader in advanced en...
07-24 20:05
Renuvion® Brings Real Transformations to the Runway at Miami Swim Week
Highlighting Real Patient Journeys and Empowering Confidence Through Loose Skin Solutions and Body Contouring CLEARWATER, Fla., May 30, 2025 /PRNewswire/ -- Apyx® Medical Corporation (NASDAQ...
05-30 21:00
Apyx Medical Affirms FY2025 Sales Guidance of $47.60M-$49.00M vs $48.03M Est
Apyx Medical (NASDAQ:APYX) affirms FY2025 sales outlook from $47.60 million-$49.00 million to $47.60 million-$49.00 million vs $48.03 million estimate.
05-08 19:07
Earnings Scheduled For May 8, 2025
Companies Reporting Before The Bell • Sempra (NYSE:SRE) is likely to report qua...
05-08 16:33
